BACKGROUND: Heart failure (HF) is one of the diseases with more health care expenditure.
INTRODUCTION
Heart failure (HF) is already a global pandemic and more than 1 million hospitalizations annually are due to HF in the United States and Europe (1) . It is estimated that 1-2% of healthcare budget in Western countries is spent in HF (2) , and HF is expected to increase both in prevalence and in health-related costs (3, 4) .
Previous studies have shown that hospitalization accounts for two thirds of the total HF-related expenditure (5-9). However, these studies included patients with reduced ejection fraction (6, (10) (11) (12) , with acute heart failure (9,12,13) or followed-up in cardiology or heart failure clinics (10, 12, 14) . Hence, these studies do not reflect the whole spectrum of HF patients. Moreover, most of the studies calculated the expenditure specifically associated with HF care. Patients with HF have multiple comorbidities, and it might be impossible to differentiate expenses specifically attributed to HF when a concomitant decompensation of comorbidity is also present. Therefore, the knowledge of how total healthcare expenditure is distributed in patients with HF (including HF-related care, and the care of other comorbidities) is of great importance.
In addition, HF expenditure is not evenly distributed across the spectrum of HF patients, with few of them accounting for the majority of costs (12) . Although some studies have analysed factors that affect expenditure in HF patients, these studies focused on patients after a HF hospitalization (15, 16) or with certain comorbidities (anaemia and chronic kidney disease) (13, 17) . Less is known on the effect of age or comorbidities on expenditure in the general HF population (18) . The identification of factors associated with an increased expenditure in a nonselected HF population might help health providers and health funding agencies to plan the distribution of resources in patients with HF.
Hence, the aim of this study was to describe the population-level distribution of healthcare resource use and expenditure in patients with HF, and identify the key independent clinical predictors associated with an increased healthcare expenditure, in a large sample of non-selected chronic heart failure patients.
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METHODS
DATA SOURCE AND STUDY DESIGN
The study was performed in the region of Catalonia (Northeastern Spain). In 2012, Catalonia had a total population of 7,553,650 inhabitants with a density of 232.8 inhabitants/Km2. Local Health Department (Catsalut) provides public universal healthcare coverage to all residents. Since 2011, the CatSalut surveillance system collects detailed information on healthcare usage for the entire population of Catalonia (19) . It includes information from the Minimum Basic Dataset for Healthcare Units registry which includes hospitalization, primary care, skilled nursing facilities and mental health network, information on pharmacy prescription and expenditure, and a registry on the billing record, which includes outpatient visits with specialists, emergency department visits, non-urgent medical transportation, ambulatory rehabilitation, domiciliary oxygen therapy and dialysis. Among the different variables collected, one variable indicates whether the hospital admission or visits are scheduled or unplanned. This information is filled in by the healthcare provider.
The registry has an automated data validation system that checks the consistency of the data and identifies potential errors. Moreover, as this information is used for provider payment purposes, external audits are performed periodically to ensure the quality and reliability of the data. These externals audits are performed whenever a suspicious deviation is detected or, if none are detected, every 3 or 5 years.
Episodes of inpatient care attended in private health centres could not be captured because private hospitals do not use the Personal Health Identification Number and therefore this information was not available for analysis. Nevertheless, use of private hospital is scarce for HF patients and the majority of unplanned HF hospitalizations are done in public hospitals: of 978.024 all-cause hospitalizations performed in Catalonia in 2013, 770,553 were done in public hospitals (79% of the total) and the rest in private hospitals. In 2013, there were 19,278 HF hospitalizations: 18,900 in public hospitals and only 378 (2%) in private hospitals. 4 The study used retrospective de-identified data from administrative databases and, therefore, the need for informed consent was waived. (14, 17) . Therefore, we analysed expenditure according to different age groups, number of comorbidities and the setting in which heart failure was diagnosed.
ASSESSMENT OF PREDICTORS OF INCREASED EXPENDITURE
We also evaluated the independent predictors associated with a yearly expenditure equal to or above the 85th percentile of the distribution in the study population. This analysis was carried out exclusively in patients who survived the whole study period (n=75,585). Predictors assessed were age, sex, comorbidities included in the Charlson Index (20), previous health care utilization and other diseases (atrial fibrillation, anaemia, valve heart disease, depression, cardiac conduction disorders). Diagnoses were obtained from discharge summaries and were defined according to the ICD-9-CM. Socioeconomic status was also used as predictor of increased expenditure and was calculated as an ecological variable linked to a basic health area and not at an individual level. It was divided in five categories (A: Very high; B: High; C:
Moderate, D: Low and E: Very Low) and was created from the proportion of residents with incomes above € 100,000 (category A) and below € 18,000 (category E), standardized by age and sex. The extreme categories A and E comprised 10% of the population, while the B and D categories represented 20% of the population each. and healthcare resource use is summarized in Table 2 . All-cause mortality rate was 14%, 53%
of patients had an emergency department visit and 31% needed an unplanned all-cause hospitalization. One-year primary care contact (physician or nurse) was high. Patients in the higher expenditure group had worse health outcomes.
A total of €536.2 M were spent in 2013 in the care of HF patients (7.1% of the 2013 healthcare budget), representing an average expenditure of €6,571 per patient/year. Figure 1A shows the percentiles of healthcare expenditure in the general population and in HF patients. Overall, HF was associated with a greater average healthcare expenditure compared to the general population. In the HF group, 10% of total expenditure was spent in the care of 1% of patients, whereas 54% of total spending was funnelled to 15% of HF patients. One per cent of Catalonia inhabitants consumed the 23% of total spending, and 51% of total spending was spent in the top 5% of inhabitants who consumed more. Figure 1B displays the distribution of healthcare-related expenditures in the HF group and in the general population of Catalonia. Among HF patients, the main source of expenditure was all-cause hospitalization, which accounted for 39% of the total. Twenty-two percent of the budget was spent in pharmacy and 19% in ambulatory care
settings. In contrast, outpatient care and hospitalization were the main source of expenses in the general population. Figure 1A shows the sources of healthcare-related expenditure in the HF group, stratified by age group. Although some differences in the resource use and expenditure were seen among the 8 different groups of age, unplanned all-cause hospitalization was the most frequent source of expenditure in all groups. In HF patients, average healthcare expenditure increased with number of comorbidities ( Figure 2B ). Thus, while the average expenditure per patient was €1,147/year in those with one comorbidity, expenditure increased to €16,806/year in patients with more than 9 comorbidities. Once again, the main source of expenditure was hospitalization, which increased exponentially as the number of comorbidities increased. Total medical expenditure was significantly higher in the group of patients with a HF diagnosis after a recent HF hospitalization, compared to patients with a remote HF hospitalization or with primary care setting HF diagnosis. In the latter group, hospitalization was also the main source of expenditure. In contrast, total medical cost in patients with HF diagnosed in the primary care setting was divided almost equally between out-patient care, pharmacy and hospitalization, and was, therefore, similar to expenditure of the whole Catalonia population. The remote HF diagnosis group had expenditure between the other two groups ( Figure 2C ).
In patients with lower healthcare resource use (those with expenditure lower than 85 th percentile), expenditure was almost similarly distributed between out-patient care, pharmacy and hospitalization. In patients with the highest healthcare resource use, almost half of the expenditure was spent in hospitalization. Dialysis, skilled nursing facility use and other (mental health care, non-urgent medical transportation, home rehabilitation and domiciliary oxygen therapy) accounted for an important part of the total expense in the latter group (Figure 3 ). This group had a total healthcare cost that was 6-times higher (€23,065 vs. 3,597 patient/year) than patients with the lowest resource use. The predictors of high expenditure are depicted in Table   3 . The presence of comorbidities, male gender, hospitalization and emergency room visits during 2012 and below-the-median socio-economic status were associated with an expenditure equal to or above 85 th percentile (i.e., higher than € 10,315 euros per patient). The area under the ROC curve for identifying patients with an expenditure equal to or above 85th percentile was 0.87 (95% CI 0.803-0.812), p<0.001.
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DISCUSSION
In this population-based analysis of 88,195 HF patients, hospitalization was the main source of healthcare-related expenditure, followed by medication and out-patient care. This distribution of expenditure was different from that of the general population, in which outpatient care and hospitalization were the main source of expenses. In HF patients, half of the total expenditure was used for the care of 15% of the patients. The presence of comorbidities, younger age and a recent HF and all-cause hospitalization were independently associated with a higher expenditure.
It is interesting to note that hospitalization was the main expenditure in HF patients whereas in the general population it was out-patient care and hospitalization. In a context of increasing prevalence of HF in the next decades (3), the knowledge of the distribution of healthcare-related expenditures may help guide the allocation of resources for the care of HF patients. Nowadays, HF is one of the diseases in which more money and resources are allocated (3, 4) . In our study, 1-year direct cost represented the 7.1% of the total yearly budget of Catalonia. This percentage is much higher than the published in other studies, in which HF cost was estimated to be 1-2% of the total budget (2). However, it must be noted that we analysed the healthcare expenditure of patients with HF, but not the expenses caused by the disease itself. Therefore, part of the calculated expense might not have been directly related to HF but be secondary to the care of other concurrent comorbidities. It is well known that health expenditure per capita is highly variable across countries. Taking into account that health expenditure per capita in Spain is close to the average value in 27 European countries (22) , and assuming that HF costs vary among countries in the same proportion as total health expenditure, the HF costs reported in this study are representative of European countries. In HF patients, hospitalization accounted for the 39% of the total cost. This allocation of resources is in contrast with other studies, in which hospitalization accounted for two thirds of cost (5-9). These differences might be explained by differences in health systems, study populations and approach used for the economic analysis (7) . Most of the studies were performed in patients with reduced ejection fraction (6,10-12), followed-up in cardiology or heart failure clinics (10, 12, 14) or with acute heart failure (9,12,13).
Hence, these studies focused on a selected group of younger HF patients in whom invasive and costly investigations and treatments are often carried out, and therefore do not reflect the whole 10 spectrum of HF patients. On the other hand, in a small study of HF patients followed in primary care settings, the distribution of healthcare-related expenditure was similar to ours (47% in hospital care, 22% in primary healthcare, 18% in medication) (23) .
Hospitalization and readmission account for the highest part of total medical costs in HF patients, and are associated with worse outcome (5, 14, 24, 25) . The greatest burden occurs within the first months after the first HF hospitalization or diagnosis (15) and patients with the longest duration of the disease have lower total costs to healthcare system in the last 6 months of life (26) . This is consistent with our data. We saw that patients with a recent HF admission or an unplanned all-cause hospitalization had the highest health care resource consumption the following year. Therefore, efforts should be made to reduce hospitalization in order to improve outcome and decrease costs. The use of skilled nursing facilities or hospice (27) , multidisciplinary organization of HF care including transitional interventions (19, 28) and telemedicine (29) are associated with a decrease in hospitalization in patients with HF and could help decrease the expenditure associated with heart failure without worsening the prognosis.
Comorbidities were frequent in our study and associated with a stepwise increase in cost. Renal failure (13), anaemia (17) , diabetes mellitus (18, 30) and other comorbidities (16, 26) are associated with increased cost in HF patients. Paradoxically, elderly patients had a total health care and pharmacy expenditure that was lower than that of younger patients (€5,166 in >84 years old vs. €7,782 in patients 65-74 years old). This difference was also seen in the study of Korves et al in which the cost for patients <65 years was $31,023 compared to $12,426 in patients 65 years and older (15) . This might be explained by the lower use of invasive treatment, as well as a higher use of skilled nursing facilities and hospice, which are not as costly as admission to general hospitals.
HF expenditure is highly variable between patients (12). In our study we saw that 15% of patients accounted for more than 50% of the total expenditure. Lower socioeconomic status is associated with a worse prognosis in chronic HF, but information on the effect of 11 socioeconomic status on HF total cost is scarce. In our study, below-the-median socioeconomic status was significantly associated with expenditure higher than 85 th percentile in HF patients.
The observed inverse relationship between socioeconomic status and expenditure can be attributed to several factors. On the one hand, inequity in health due to economic causes could explain it: people with higher incomes may have a better health status than low-income population. On the other hand, patients might have a selective private and public resources use.
Patients with dual coverage could use private coverage to have access to certain tests (and avoid the waiting lists) or buy inexpensive drugs directly without the need to have them subsidized, whereas low-income population would not be able to afford private coverage and would always use the public system.
STUDY LIMITATIONS
Patients who died during the study period were excluded from the assessment of predictors of increased expenditure. Although this exclusion could lead to bias, it is also true that the cost of these patients after their death was zero. Therefore, the inclusion of dead patients in the analysis could lead to a possible bias in the calculation of the odd ratios of risk factors and, consequently, to errors in interpretation when diseases with high mortality are analysed.
For example, a particular tumour could appear as a protector factor for expenditure even though antineoplasic treatments are expensive. Regarding the possible solutions for this bias, we opted for the simplest solution and we analysed only patients alive throughout the year. This strategy has two main advantages: simplicity and robustness. In contrast with several similar strategies, each of which introduces some sort of bias, we believe it is better to use the simplest and easiest strategy to explain and understand the data. Moreover, the strength of this work is that as it is a population-based study with real data, there is no need for methodological sophistication when a simpler strategy can be used.
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The use of a general population database minimized selection bias and allowed to analyse real world population (31) but the use of administrative data to identify heart failure patients may lead to HF misdiagnosis. However, studies have shown that most of HF diagnoses in administrative databases do correspond to true HF cases (32, 33) .
CONCLUSIONS
Heart failure is a disease that consumes a high amount of healthcare resources and expenditure. Although the main expenditure was hospitalization, its weight in the total expenditure varied depending on comorbidities, age and previous hospitalization. The knowledge of how expenditure is distributed in a non-selected HF population might allow health providers and health funding agencies to plan the distribution of resources in patients with HF.
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